Testicular cancer: low testosterone and the metabolic syndrome
Cure rates for stage 1 testicular cancer are reaching 100%. However, long-term treatment-related side effects pose their own health risks. Regular follow up and monitoring are important for early detection and timely treatment of conditions such as testosterone deficiency and metabolic syndrome.
Click here to access the podcast on the article.